Relative cost of multidrug-resistant TB medicines in Europe

Int J Tuberc Lung Dis. 2023 May 1;27(5):341-344. doi: 10.5588/ijtld.23.0026.
No abstract available

Publication types

  • Editorial
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Antitubercular Agents* / therapeutic use
  • Europe
  • Humans
  • Tuberculosis, Multidrug-Resistant* / drug therapy

Substances

  • Antitubercular Agents